Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

TiE Boston recognizes Purnanand Sarma, Ph.D. President & CEO of Immunome, as 2020 Lifetime Achievement Awardee
  • USA - English

Dr. Sarma to be honored at the 2020 TiE Boston Gala, Keynote Fireside Chat with Kiran Mazumdar-Shaw, CMD of Biocon


News provided by

TiE Boston

Dec 09, 2020, 06:30 ET

Share this article

Share toX

Share this article

Share toX

BOSTON, Dec. 9, 2020 /PRNewswire-PRWeb/ -- TiE Boston, a not-for-profit dedicated to fostering entrepreneurship, announced that the recipient of its 2020 Lifetime Achievement Award would be Purnanand Sarma, President and CEO of Immunome, Inc. The award will be presented at this year's annual gala to be held virtually on Dec 18th at 7pm EST. The theme of the 2020 Gala is "A Whole New World" and will feature a virtual fireside chat with Kiran Mazumdar-Shaw, CMD of Biocon.

TiE Boston President, Anu Chitrapu, shared, "Dr, Sarma's achievements are extraordinary in any time period, but in this COVID era, his phenomenal achievements in Health Sciences make his contributions invaluable! TiE Boston is honored to recognize him with the Lifetime Achievement Award!"

"I am deeply honored to receive this prestigious award and thank TiE Boston, an incredible organization fostering innovation, growth and the development of next generation entrepreneurs," said Dr. Sarma. "I am fortunate to have the opportunity to work with an amazing group of individuals in an extremely fulfilling TiE Boston ecosystem."

This year's Lifetime Achievement Award will be conferred upon Dr. Sarma in recognition of his extraordinary journey and his invaluable contribution in the fields of science, business and entrepreneurship. Past awardees have included Venkat Srinivasan, Amar Sawhney, Mukesh Chatter, Jit Saxena, Desh Deshpande, Anil Singhal and Anant Agarwal.

2018 TiE Boston Lifetime Achievement Awardee and serial entrepreneur, Dr. Amar Sawhney, shared, "Sarma has shown an incredible breadth of talent from key roles in larger pharma, to entrepreneurial roles at Taris, and now taking on incredible challenges that we are all facing with COVID19 and running a public emerging biotech. His contributions span many disease states with meaningful advances. He has been incredibly generous with his time in mentoring efforts. All these exemplify the TiE Lifetime achievement Award. We are proud to have Sarma in our community."

Dr. Purnanand Sarma serves as the President and Chief Executive Officer of Immunome, Inc., a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics, with a focus on oncology and infectious diseases including COVID-19. Sarma has more than 25 years of experience in the pharmaceutical industry across multiple R&D platforms and led the development of therapeutics in companies ranging from venture-backed biotechnology start-ups to large cap pharmaceutical companies. He was most recently the President & CEO of Taris Biomedical, based in Lexington, MA, which he built into a leader in therapeutic urology, and was acquired by Johnson & Johnson in December 2019. Earlier at Taris Biomedical, in addition to raising more than $100M in equity capital, he also sold one of Taris' products to Allergan in a deal worth up to $587M. Prior to Taris, Sarma held leadership positions at Cephalon Corporation, Nektar Therapeutics and Glaxo SmithKline. Dr. Sarma received a PhD in Pharmaceutics from the University of Minnesota, and a B.Pharm degree from Andhra University, Visakhapatnam, India.

Sarma recently joined Immunome as its President, CEO and Board Member. Under his leadership, the company completed its initial public offering in October 2020. Immunome's proprietary technology leverages immune response from patients who successfully learned to fight off the disease, specifically by probing their highly-educated memory B-cells, to discover novel therapeutic antibodies, and their targets. The company is currently focused on developing drugs to treat cancer, and infectious diseases, including COVID-19. In July 2020, the United States Department of Defense awarded a $13.3 million contract to Immunome for the development of a novel biosynthetic convalescent plasma (BCP) as a potential new approach to combat the COVID-19 pandemic.

TiE Boston Executive Director, Simone LaPray, shared, "Dr. Sarma has been a long time charter member and contributor to TiE Boston. In his busy schedule, he would still find time to foster the next generation of entrepreneurs at TiE Boston - from mentoring our companies in ScaleUp, attending our angel investor meetings and even dedicating a Saturday morning in Kendall Square to work with high school youth in our TiE Young Entrepreneurs program."

The "2020 President's Award" goes to Nikhil Bhojwani, Managing Director of Recon Strategy, for his work in the fight against the pandemic. As a result of his HBR article, co-written with Dr. Atul Gawande, the Assurance Testing Alliance was formed. With his continued involvement, the COVID testing platform set up by CIC-Health, is based on the blueprint outlined in the article and has resulted in hundreds of thousands of tests done across multiple states and hundreds of organizations.

This year's TiE Boston Gala will also host a virtual keynote fireside chat with special guest, Kiran Mazumdar-Shaw, Chairperson and Managing Director of Biocon, Asia's leading biopharmaceuticals enterprise. Ms. Kiran Mazumdar-Shaw is a pioneering biotech entrepreneur, a healthcare visionary, a global influencer and a passionate philanthropist. She is a pioneer of India's biotech industry and founder of Biocon. Ms. Mazumdar-Shaw is the proud recipient of two of India's highest civilian honours, the Padma Shri (1989) and the Padma Bhushan (2005). She was also honoured with the Order of Australia, Australia's Highest Civilian Honour in January 2020. In 2016, she was conferred with the highest French distinction - Knight of the Legion of Honour. She has been named as the winner of EY World Entrepreneur of the Year™ 2020 Award, which is a testimony to her entrepreneurial journey of over four decades. She has been elected as a full-term member of the Board of Trustees of The Massachusetts Institute of Technology (MIT), USA, and also serves as a member of the National Academy of Engineering (NAE), USA.

About TiE Boston:

TiE Boston connects tomorrow's founders with today's entrepreneurs, executives and venture capitalists. Founded in 1997 by entrepreneurs who immigrated from the Indus region, TiE Boston champions inclusion in innovation by blending the fundamentals of entrepreneurship with traditional Indian values that place importance on community, mentorship, and long-term relationships.

TiE Boston is one of the region's largest and oldest organizations supporting the Massachusetts entrepreneurial ecosystem, focused on supporting entrepreneurs throughout their lifecycle — from ideation to creation, through growth, wealth creation and ultimately, support of future founders.

The TiE Boston community encompasses students, founders, experienced entrepreneurs, angel investors, and venture capitalists. Its programs foster trusted, long-term relationships between its participants — span education, mentoring, networking, and funding.

For more information about TiE Boston, visit https://www.tieboston.org/.

Media Contact

Simone LaPray, TiE Boston, +1 (617) 312-3825, [email protected]

Twitter

SOURCE TiE Boston

Related Links

https://www.tieboston.org

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.